<DOC>
	<DOC>NCT00780481</DOC>
	<brief_summary>T-PA release is impaired in obese subjects. In order to have a better mechanistic understanding of t-PA release, we will compare t-PA release to Flow Mediated Vasodilation, Radial Artery Tonometry, and other markers of endothelial function and oxidative stress.</brief_summary>
	<brief_title>Characterization of Brachial Arterial t-PA Release, Endothelial Function, Obesity and Inflammation</brief_title>
	<detailed_description />
	<mesh_term>Obesity</mesh_term>
	<mesh_term>Inflammation</mesh_term>
	<mesh_term>Bradykinin</mesh_term>
	<mesh_term>Kininogens</mesh_term>
	<criteria>Inclusion criteria: 1. Adults 18 years and greater 2. Healthy Exclusion criteria: 1. PVC &lt; 30 2. Hypertensive subjects on ACE inhibitors 3. Pregnant or nursing mothers 4. Diabetic with HbA1C &gt; 7.5 or stigmata of end organ damage (neuropathy, retinopathy, nephropathy, cardiomyopathy) 5. Cholesterol &gt; 30 mg/dL above NCEP accepted level based on cardiac risk. 6. Triglycerides &gt; 200 7. Previously diagnosed obstructive coronary artery disease, myocardial infarction or left ventricular dysfunction (with or without a history of congestive heart failure) 8. Renal insufficiency (Creatinine ≥ 1.5 mg/dl) 9. History of cerebrovascular disease 10. Any chronic inflammatory disease (rheumatologic, inflammatory bowel disease, etc) 11. Uncontrolled Stage 2 Hypertension (160/100 mmHg), or end organ damage due to hypertension (left ventricular hypertrophy, atrial fibrillation, hematuria, renal insufficiency, prior cerebrovascular disease). 12. Angiotensin converting enzyme inhibitor use 13. Coagulopathy (INR ≥ 1.5, PTT ≥ 1.5 x control) 14. Other chronic medical illnesses at the discretion of the investigators</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2016</verification_date>
	<keyword>Obesity</keyword>
	<keyword>Endothelial Function</keyword>
	<keyword>Fibrinolytic Balance</keyword>
	<keyword>Baseline</keyword>
</DOC>